Aegerion seeking EU, U.S. approval of HoFH therapy

Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) submitted an NDA to FDA and an MAA to EMA for lomitapide to treat homozygous familial hypercholesterolemia (HoFH). The compound is a small molecule microsom...